Analysts await Hansen Medical, Inc. (NASDAQ:HNSN) to report earnings on Mar, 14 for the fiscal quarter ending Dec 2015.

They expect $-0.54 EPS, up 48.15% or $0.26 from last year’s $-0.8 per share.

At the moment 1 analyst is watching Hansen Medical, Inc. (NASDAQ:HNSN), 0 rate it “Buy”, 0 “Outperform”, 1 “Underperform”, 0 “Sell”, while 0 “Hold”.

The biggest institutional shareholders in Hansen Medical, Inc. include BlackRock Advisors LLC which owns 500 K million shares in the company valued at $2.19 million. Vanguard Group Inc is the second biggest holder with 229 K million shares currently valued at 1.00 million whilst Westerly Capital Management LLC has 101 K million shares valued at 441.88 K million.

Total shares held by institutions as of the most recent company filings are 1,387,545 with a reported 47,799 bought and 111,203 sold. These holdings make up 8.39% of the company’s outstanding shares.

Currently insiders hold 9,608,617 shares in the business which makes up 50.91% of shares. The biggest holder currently is Jack W Schuler who owns 5,319,769 shares (28.19% of those outstanding), whilst Dr. Frederic H. Moll,M.D. holds 2,640,077 (13.99% of shares outstanding) and Steven M. Van Dick holds 231,996 (1.23% of shares outstanding).

The stock decreased 5.62% or $0.15 during the last trading session, hitting $200000.00. Hansen Medical, Inc. (NASDAQ:HNSN) has risen 100% over the past 6 months and is uptrending.